More so than almost all other scientific fields, our knowledge, understanding and expertise in biology has increased at a phenomenal pace over the past few decades. Since the high throughput sequencing power used in the human genome project was unleashed at the beginning of the 21st century, multiple '-omics' disciplines now characterise a diverse field that offers such enormous potential for medicine, food production, wellbeing and human expression.
As we now understand much more about the most complex of biological systems, inventors and innovators are able to address the most pressing and impactful needs we face today.
Thank you
The most cutting-edge life sciences businesses have become adept at marrying advances in computer technology with the power of automation to make rapid improvements and enhancements to our ability to understand and address complex challenges. These technology-led developments have become almost as important to their operations as knowledge of the underlying biological factors involved. These businesses are at the forefront of research and development, and we are delighted to play our part in helping them to thrive for the wider benefit of society.
Our team of attorneys have PhDs and real world research and development experience from the most prestigious institutions in Europe and the UK. We are highly experienced in multiple disciplines from biologics and therapeutics to diagnostics and modelling, from regenerative medicine to synthetic biology and bioinformatics.
Our attorneys combine technical excellence with business insight to act for a wide range of clients from those at the earliest stage of their commercial journey where we can guide the development and implementation of an intellectual property portfolio through to multinational corporations, acting as an extension of their teams.
Keltie’s work in the life sciences sector includes:
The life science team at Keltie is resolutely commercial in our approach to intellectual property protection. The underlying business case is as important for framing our advice as the nature of the technology itself. Our team of attorneys in both the patents and trade marks handle matters of global importance. As a result we are adept at advising on issues that cover multiple markets from Europe to North America, Asia and beyond.
Our approach focuses on putting together the best team of attorneys for your business’ needs from our diverse talent pool to ensure your intellectual property portfolio is planned, executed and maintained to the highest standards to safeguard your rights.
Sectors you may be interested in
People who work in this area
Sectors we work in
23.08.2024
G 1/23 - Potential changes ahead for what constitutes “state of the art”?The EPO Enlarged Board of Appeal has now issued its preliminary (and non-binding) opinion on G 1/23. This referral (from the Technical Board of Appeal in T 438/19) seeks to clarify whether a commercially available product, with an undisclosed composition or internal structure, must be analysable and reproducible by the skilled person in order to constitute prior art under Article 54(2) EPC.
21.03.2024
UPC Court of Appeal reverses Preliminary Injunction in first substantive decisionThe Court of Appeal of the Unified Patent Court (UPC) recently published its first decision considering substantive issues, in which it overturned a first instance decision of the Munich local division (NanoString (appellants) v 10x Genomics (respondents), UPC_CoA_335/2023).
Thank you
